Home About Us Products Manufacturing Quality Contact Feedback   Chemotherapy Protocols   Bleomycin Carboplatin Cisplatin Doxorubicin Etoposide Vincristine   Cancer Acute Myeloid Leukemia Reference Zander et al.1     Chemotherapy Regimen Etoposide Dose busulfan, etoposide, cyclophosphamide 30-60 mg/kg 4 days before ABMT   Condition PBPC mobilization Reference Kanfer et al.2     Chemotherapy Regimen Etoposide Dose high-dose etoposide + G-CSF 1.6-2.0 g/m² over 10 hr   Cancer SCLC/NHL Reference Higa et al.3     Chemotherapy Regimen Etoposide Dose etoposide prolonged infusion 25 mg/m² for 35 days   Cancer SCLC Reference Gridelli et al.4     Chemotherapy Regimen Etoposide Dose carboplatin, epirubicin, etoposide + G-CSF 100-140 mg/m², days 1-3, 3-week cycles   Cancer NSCLC Reference Helsing et al.5     Chemotherapy Regimen Etoposide Dose carboplatin, etoposide 120 mg/m², day 1-5, 4-week cycles   References: 1. A.R. Zander et al. Clin. Cancer Res. 3 (1997) 2671-5. 2. E.J. Kanfer et al., Br.J. Cancer 78 (1998) 928-32. 3. G.M. Higa et al., Pharmacother. 19 (1999) 101-7. 4. C. Gridelli et al., Am.J.Clin.Oncol. 19 (1996) 589-591. 5. M. Helsing et al., Eur.J. Cancer 34 (1998) 1036-44.   Sitemap | Privacy Policy | Terms and Conditions Credits | Ointment Manufacturer | Pharma Manufacturer © 2008 Neiss Labs Pvt. Ltd. All rights reserved.